← Eichor
Study identifier: NCT03344484 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Midline Versus Paramedian Approaches in Treating Degenerative Lumbar Spondylolisthesis

Condition: Spondylolisthesis, Lumbar Region  ·  Sponsor: Nova Scotia Health Authority

PhaseNA
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

For the increasing numbers of patients undergoing fusion procedures for the degenerative lumbar spine, infection and re-operation can negatively impact outcomes. Numerous observational and retrospective reviews have shown advantages to para-median versus midline approaches; however, recent systematic reviews have shown a need for a well-powered, prospective randomized control trials comparing both exposures. As a step towards a long-term goal of an RCT to address this issue, the purpose of this pilot study is to gather initial data to examine whether operative approach impacts the short-term infection rate, re-operation rate, length of stay, and overall costs to the system. Patients deemed appropriate surgical candidates with single or two-level degenerative spondylolisthesis will be approached for participation, and randomized into either the midline or paramedian group. Initial follow-ups will be at 2 and 6 weeks, and 3 months. Infection rates, inpatient and outpatient adverse events, re-operation rates, radiation exposure and costs will be determined. Cost effectiveness analysis will be estimated comparing each procedure using a bottom-up estimation. Post-operative wound infection can have a significant effect on patient short and long term outcomes. If a significant difference in infection rate is demonstrated, as well as lower re-operation rates, shorter stays, and decreased overall costs, adoption of paramedian approaches to single or two-level fusions of the lumbar spi…

This description comes directly from the study's public registry record.

Talk to the study team

Andrew Glennie, MD  ·  902-473-3707  ·  andrew.glennie@nshealth.ca

Always discuss trial participation with your own doctor first.

Locations (1)

QEII Health Sciences Centre - Halifax Infirmary siteHalifax, Nova Scotia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03344484